Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction
- 22 December 2005
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 112 (1), 52-58
- https://doi.org/10.1016/j.ijcard.2005.09.051
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Upregulation of CD40 and CD40 Ligand (CD154) in Patients With Moderate HypercholesterolemiaCirculation, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failureThe American Journal of Cardiology, 2000
- Enhanced inflammatory response in patients with preinfarction unstable anginaJournal of the American College of Cardiology, 1999
- Requirement for CD154 in the progression of atherosclerosisNature Medicine, 1999
- Cardiac Myocytes Produce Interleukin-6 in Culture and in Viable Border Zone of Reperfused InfarctionsCirculation, 1999
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998
- Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40Circulation, 1997
- Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosisProceedings of the National Academy of Sciences, 1997
- Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial InfarctionCirculation, 1995